The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

Based on therapeutic area, the artificial intelligence (AI) in drug discovery market is segmented into oncology, infectious ...

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...

GSK, formerly known as GlaxoSmithKline, continues to distinguish itself through its vast array of medicines, vaccines and consumer health care products ... in oncology, immunology and ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

New start-up Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical-stage inflammation and immunology ... including GSK’s IL-5 ...

GSK's global head of respiratory and immunology R&D, Kaivan Khavandi, said that CRSwNP affects millions of people around the globe, with current treatment often leading to prolonged exposure to ...